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Abstract  
Introduction: Although there has been a growing concern over the possible damaging effect of 
salpingectomy on ovarian reserve, this issue remains uncertain. The purpose of this meta-
analysis was to test the hypothesis that salpingectomy may compromise ovarian reserve. 
Material and methods: A detailed search was conducted using MEDLINE, Embase, Dynamed 
Plus, ScienceDirect, TRIP database and the Cochrane Library from January 2000 to November 
2016. All cohort, cross-sectional and randomized controlled studies investigating changes in 
circulating anti-Müllerian hormone (AMH) after salpingectomy were considered. Thirty-seven 
studies were identified, of which eight were eligible. Data were extracted and entered into 
RevMan software for calculation of the weighted mean difference (WMD) and 95% confidence 
interval (CI). Two groups of studies were analyzed separately including group 1 (six studies, 
n=464) comparing data before and after salpingectomy and group 2 (two studies) comparing 
data in women who have undergone salpingectomy (n=169) vs. healthy controls (n=154). 
Results: Pooled results of group 1 studies showed no statistically significant change in serum 
AMH concentration after salpingectomy (WMD, -0.10ng/ml; 95% CI; -0.19 – 0.00, I2=0%). 
Similarly, meta-analysis of group 2 showed no statistically significant difference in serum 
AMH concentration between salpingectomy group and controls (WMD, -0.11ng/ml; 95% CI; -
0.37 – 0.14, I2=77%). Subgroup analyses based on laterality of surgery, type of AMH kit and 
participants’ age (<40) still showed no statistically significant changes in circulating AMH. 
Conclusion: Salpingectomy does not seem to compromise ovarian reserve in the short-term. 
However, the long-term effect of salpingectomy on ovarian reserve remains uncertain. 
 
Keywords 
salpingectomy, ovarian reserve, anti-Müllerian hormone, ovarian function, laparoscopy. 
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Abbreviations 
AMH  anti-Müllerian hormone 
FSH  follicle stimulating hormone  
AFC  antral follicle count 
WMD   weighted mean difference 
CI confidence interval 
IVF  in vitro fertilization 
RCT  randomized controlled trials  
 
Key Message 
This meta-analysis investigates the possible damaging effect of salpingectomy on ovarian 
reserve. The results confirmed the short-term safety of salpingectomy with no effect on 
circulating anti-Müllerian hormone, which is the main marker of ovarian reserve 
 
Introduction 
Since its introduction by Lawson Tait in 1883, salpingectomy has been one of the most 
commonly performed surgical procedures in gynecological practice worldwide (1). Common 
indications include ectopic pregnancy and salpingitis (for example symptomatic hydro- or pyo-
salpinx). More recently, it has been widely accepted that salpingectomy should be offered to 
women with asymptomatic hydrosalpinx who require in vitro fertilisation (IVF) (2). Moreover, 
with emerging evidence suggesting a tubal origin for ovarian cancer, salpingectomy is 
increasingly performed during hysterectomy in women conserving their ovaries (3,4). 
This rising trend in salpingectomy has been associated with a rising concern over its potential 
damaging effect on ovarian reserve due to possible concomitant damage of ovarian blood 
supply given the close proximity between tubal and ovarian arteries. It has therefore been 
hypothesized that salpingectomy could interrupt ovarian blood supply thereby compromising 
ovarian blood flow with a consequent decline in ovarian reserve. This hypothesis is supported 
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by a previous study showing post-salpingectomy impairment of the ovarian blood flow on the 
operated side (5). Another study detected an increase in vascular resistance in ovarian arteries 
following Filshie clip sterilization (6). 
As most women requiring salpingectomy are relatively young and still wishing to preserve 
their fertility potential, it will be critical to evaluate any possible impairment of their ovarian 
reserve. This will help both the clinician and the patient when considering the need for 
salpingectomy. 
Although there are numerous markers for ovarian reserve, it is now universally agreed that 
circulating anti Müllerian hormone (AMH) is considered the most reliable test.  It has been 
found to correlate well with the actual histological count of the ovarian follicles (7). 
Furthermore, the stability of serum AMH level throughout the menstrual cycle with minimal 
variations makes it an ideal marker for detecting relatively small changes in ovarian reserve 
following salpingectomy (8). 
To date, there are several studies evaluating the effect of salpingectomy on ovarian reserve (9-
22). Given the small size of these studies, further evidence is required to address this important 
topic. This meta-analysis was therefore designed to investigate the impact of salpingectomy on 
ovarian reserve as determined by serum AMH concentrations. 
 
Material and methods 
This analysis was conducted according to the Preferred Reporting Items for Systematic 
Reviews and Meta-analyses (PRISMA) guidelines (23) and was registered in PROSPERO 
(Registration number: CRD42016052576). 
 
Eligible criteria  
We considered all published cohort (retrospective and prospective) and cross-sectional studies 
as well as randomized controlled trials (RCTs) that investigated changes in serum AMH levels 
following salpingectomy.  
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Outcome measures 
Primary measure 
This included changes in the serum AMH concentration after salpingectomy. 
Secondary measures 
This included changes in serum follicle stimulating hormone (FSH) concentration and antral 
follicle count (AFC) after salpingectomy. 
 
Search strategy 
A detailed electronic search was conducted using numerous databases from January 2000 to 
November 2016 to identify available research articles investigating the effect of salpingectomy 
on ovarian reserve as estimated by changes in serum AMH levels (Supporting Information 
Table S2). Searched databases included MEDLINE, Embase, Dynamed Plus, ScienceDirect, 
TRIP database and the Cochrane Library.  Medical Subject Headings (MeSH) terms used 
included: Salpingectomy, Ovarian Function, Ovarian Reserve, Pregnancy, Laparoscopy, 
Laparotomy, Anti-Müllerian Hormone, Follicle Stimulating Hormone and Fertility.  Keywords 
searched included: Antral Follicle Count, Bilateral Salpingectomy, and Unilateral 
Salpingectomy. Papers were limited to the English Language, Human Studies and Adult 
Females. All searches were conducted by the first author (AM) and then independently 
repeated using the same criteria by an accredited clinical librarian (CJ). All related reports were 
retrieved, and their reference lists were revised manually to categorize further studies. We also 
considered published abstracts from conferences. 
 
Study selection 
Two investigators (AM, AY) independently screened the title and abstract of all identified 
articles to assess relevance to our meta-analysis. In case of disagreement, the full text was 
retrieved and reviewed independently by another author (SA) for a final decision. 
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Data extraction  
All retrieved articles were assessed according to a standardized format including; study design, 
methods, participant characteristics, intervention, and results. Two investigators (AM and AY) 
scored the studies and collected the information independently. In the case of discrepancies in 
scoring between the two investigators, a consensus was reached after discussion or after 
involvement of the senior investigator (SA). In five studies, the mean±SD AMH serum 
concentration was missing (11,19,20,21,22). Two authors provided the missing data (mean±SD 
AMH, type of AMH kit and mean±SD age of participants) when contacted via email (11,21) 
The author of another study was not contactable (20). Authors of the remaining two studies 
were contacted by email, but no response was received (19, 22). 
 
Quality of included studies and risk of bias assessment  
Modified Newcastle-Ottawa scale was utilised for assessing the quality and risk of bias of the 
included studies. Each article was scored according to three categories including selection 
(maximum three stars), comparability (four stars), and outcomes (two stars) (24,25). Selection 
was rated according to recruitment bias, selection of consecutive women and power 
calculation. Comparability was assessed based on adjustment of analysis for four confounders 
including women’s age (<40), baseline serum AMH (≥ 3.1ng/ml), laterality of surgery and 
associated hysterectomy. Outcome was scored according to completeness of at least three-
month follow-up after surgery. In the current analysis, we have given more weight to 
comparability factors and used the cut-off level of six stars with a minimum of three stars in the 
comparability category (24,25). Table 1 shows the results of quality scores of the studies 
included in this analysis. 
 
Data analysis  
This meta-analysis included two groups of studies. Group 1 involved studies comparing 
changes of outcomes (AMH, FSH, AFC) before and after salpingectomy. Group 2 included 
studies comparing outcomes between women who had undergone salpingectomy vs. healthy 
controls. In both groups, mean±SD serum AMH and FSH concentrations and AFC were 
extracted from the individual studies and pooled using RevMan software (Review Manager, 
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version 5.1, The Cochrane Collaboration, 2011; The Nordic Cochrane Centre, Copenhagen, 
Denmark). The weighted mean difference (WMD) was calculated in both groups. Statistical 
heterogeneity was assessed by chi-squared (χ2) test and I2 statistics. A χ2 statistic larger than its 
degree of freedom or an I
2
 higher than 50% was indicative of significant heterogeneity between 
studies. When heterogeneity was significant, a random-effect model was used for meta-
analysis. Fixed effect meta-analysis was used when there was no significant heterogeneity.  
The initial analyses included data from all studies in both groups. Further subgroup analyses of 
AMH levels were then performed based on the laterality of the excised fallopian tube, AMH 
kits and age of participants. 
 
Results 
Thirty-seven studies identified through the electronic search were screened for relevance, of 
which eight were deemed eligible for the meta-analysis (Fig. 1). 
Excluded studies  
Of all identified studies, seven did not measure any ovarian reserve marker and were excluded. 
Nineteen other studies did not use circulating AMH as an ovarian reserve marker and were 
excluded. Three further studies were excluded due to missing the mean±SD AMH data 
(Supporting Information Table S1). Authors of these studies were contacted to provide the 
missing data as explained above.  
 
Included studies 
Details of the included eight studies are shown in Table 2 and Table 3. 
 
Study design 
This systematic review included three prospective cohorts (11,14,21), two retrospective cohorts 
(10,13), one cross-sectional study (15) and two RCTs (9,12). In one RCT, the two arms 
including women undergoing salpingectomy (with and without removal of mesosalpinx) were 
combined and used as a cohort study for this meta-analysis (12). In the other RCT comparing 
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laparoscopic hysterectomy with and without bilateral salpingectomy, the salpingectomy arm 
was used as a cohort study and included in our meta-analysis (9). 
 
Participants 
In four studies, participants had normal fallopian tubes, which were removed during a 
gynecological procedure including hysterectomy (9,10,21), myomectomy or sterilization (12). 
In three other studies, participants underwent salpingectomy due to tubal ectopic pregnancy 
(11,14,15). In the remaining study, women underwent salpingectomy due to tubal pathology 
including Tubo-ovarian abscess, ectopic pregnancy or hydro-salpinx (13). 
All studies stated inclusion and exclusion criteria, which were appropriate, except one study 
which was a conference abstract (11). We successfully obtained missing data after contacting 
the author of this study.  
 
Salpingectomy surgery 
All participants underwent salpingectomy through laparoscopy except in two studies, which 
included women undergoing salpingectomy through laparotomy or laparoscopy (15,21). All 
studies specified the laterality of salpingectomy, which was bilateral in four studies 
(9,10,12,21) and unilateral in three studies (11,14,15). The remaining study compared 
unilateral vs. bilateral salpingectomy (13). Both unilateral and bilateral arms were combined 
and used in the initial analysis. Each arm was then used separately in the sub-analysis (13). 
Findley and co-workers tended to preserve mesosalpinx during salpingectomy (9). Venturella 
and co-workers compared salpingectomy with preservation of mesosalpinx (standard 
salpingectomy) vs. salpingectomy with removal of mesosalpinx (wide technique 
salpingectomy) (12). Six studies did not report whether or not the mesosalpinx was preserved 
(10,11,13,14,15,21).  
 
Length of follow up after salpingectomy 
The length of follow up after salpingectomy was three months in four studies (9,10,12,14), four 
months in one study (11), six months in one study (21), 18 months in one study (15) and not 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
specified in one study (13). One study reported two postoperative measurements at four to six 
weeks and at three months (9). 
 
AMH kits 
Four kits were used to measure serum AMH levels. The modified AMH Gen II enzyme linked 
immunosorbent assay (ELISA) (Beckman Coulter, Chaska, MN, USA) was used by four 
studies (10-12,14). The intra and inter-assay coefficients of variation for the AMH were both 
below 10%, with a detection limit of 0.08ng/m. Two studies used the AMH ELISA Ansh Labs 
assay (Ansh Labs, UK) (9,15). The intra and Inter-assay coefficients of variation for the AMH 
were 0.02 (2.22/95) and 7.81 (15.62/2), respectively, with a detection limit of 0.06 ng/ml. One 
study measured AMH by an enzyme linked immunosorbent assay using a Bio-Rad iMark 
microplate absorbance reader with reagent kits from Bio-Rad (Bio-Rad Laboratories Inc, 
Hercules, CA) (13). The inter-assay coefficient of variability is 10%, and the intra-assay 
coefficient of variability is 15%. The remaining study measured AMH using a commercially 
available ELISA kit (Cusabio Biotech Co., Ltd., Hubei, People’s Republic of China). The 
detection sensitivity of this assay was 0.14 ng/ml and the inter-assay coefficient was 14.2% 
(21). AMH values reported in pmol/l were converted to ng/ml using a universally accepted 
laboratory formula: 1 ng/ml = 7.14 pmol/l (26).  
 
Potential source of bias  
In all included studies, recruitment of participants followed a consecutive fashion. The 
selection method was clearly defined, rendering it easy to assess selection bias. 
 
Overall pooled results for all studies 
Pooled analysis of group 1 studies (n=464) revealed no statistically significant change in serum 
AMH levels after salpingectomy (WMD, -0.10ng/ml; 95% confidence interval (CI); -0.19 – 
0.00, I
2
 = 0%) with low heterogeneity between studies (Fig. 2) (9-12,14, 21). Similarly, in 
group 2, overall analysis of two studies showed no statistically significant difference between 
the salpingectomy group (n=169) and control group (n=154) (WMD, -0.11ng/ml; 95% CI; -
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0.37 – 0.14, I2=77%) with high heterogeneity between studies (Fig. 3) (13,15). 
 
Subgroup analysis 
Laterality of salpingectomy 
In group 1 studies, bilateral salpingectomy was reported in four studies including 383 women 
(9,10,12,21). Pooled analysis of these studies showed no statistically significant change in 
postoperative serum AMH level (WMD, -0.10ng/ml; 95% CI; -0.20 – 0.00; I2= 0%). Analysis 
of two studies with unilateral salpingectomy (n=81) revealed no statistically significant change 
in serum AMH concentration after surgery (WMD, 0.10ng/ml; 95% CI; -0.45 – 0.65; I2=0%) 
(11,14). 
In group 2 studies, unilateral salpingectomy was reported in two studies (13,14). Pooled 
analysis showed no statistically significant difference between salpingectomy group (n=128) 
and control group (n=154) (WMD, -0.11ng/ml; 95% CI; -0.38 – 0.16; I2= 79%). 
Studies using different AMH assays 
In group 1, analysis of four studies (n=346) using modified Gen II AMH kit showed no 
statistically significant changes in AMH concentration after salpingectomy (WMD, -0.07; 95% 
CI; -0.17 – 0.04; I2=0%) (10-12,14).  
Participants’ age 
In group 1, pooled analysis of three studies including 96 participants aged <40 revealed no 
statistically significant change in serum AMH level (WMD, -0.05; 95% CI; -0.47 – 0.57; I2= 
0%) (9, 11, 14). In group 2 studies, all participants were aged under 40 and a sub-analysis was 
therefore not performed (13,15). 
Analysis of three studies in group 1 (n=368) with participants >40 also revealed no statistically 
significant change in serum AMH concentration (WMD, -0.10 ng/ml 95% CI; -0.20 – 0.00; I2= 
0%) (10,12,21).  
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Sensitivity analysis 
Sensitivity analysis in group 1, included the three studies with participants aged <40 (n=96), 
which were also the studies with low risk of bias. The results of this analysis are shown above. 
In group 2, only one study scored high in the risk of bias assessment and a sensitivity analysis 
was therefore not performed (15). 
 
Secondary outcomes 
In group 1, three studies including 368 women measured serum FSH concentrations (10, 12,21) 
and two studies (n=265) measured AFC after salpingectomy (10,12). Pooled analysis of these 
studies revealed a statistically significant increase in circulating FSH (WMD, 1.75 IU/L; 95% 
CI; 0.69 – 2.81; I2= 81%), but no significant change in AFC following bilateral salpingectomy 
(WMD, -0.30; 95% CI; -0.64 – 0.05; I2= 0%).   
In group 2, two studies measured serum FSH and AFC (13,15).  Meta-analysis of these studies 
showed no significant difference in serum FSH levels between salpingectomy (n=169) and 
control (n=154) groups (WMD, 0.58 IU/L; 95% CI; -0.21 – 1.37; I2=63%). On the other hand, 
pooled analysis showed a significantly lower AFC in salpingectomy group compared to the 
control group (WMD, -0.66; 95% CI; -1.27 – -0.06; I2=42%). 
 
Discussion 
To the best of our knowledge, this is the first systematic review to investigate the impact of 
salpingectomy on ovarian reserve as determined by circulating AMH. The overall analysis as 
well as subgroup analysis based on laterality, age and AMH kits revealed no short-term 
changes in serum AMH concentrations after salpingectomy.  
These results are surprising given the expected post-salpingectomy damage to ovarian reserve 
as a result of impairment of ovarian blood supply as shown in several previous studies (5,6,13). 
Furthermore, it was interesting to see that even wide (radical) and bilateral salpingectomy did 
not cause any decline in serum AMH concentration despite the expected increase in damage to 
the ovarian blood supply. Our results are in disagreement with a recent systematic review, 
which reported post-salpingectomy impairment of ovarian reserve as determined by ovarian 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
response to hyperstimulation during IVF (27). This discrepancy could be explained by the 
differences in the methods used to assess ovarian reserve between our meta-analysis (AMH) 
and the previous systematic review (ovarian response during IVF).  
It was also surprising to see that ovarian reserve was not affected after salpingectomy even 
when performed with hysterectomy despite the loss of an important ovarian blood supply from 
the utero-ovarian vessels. It may be argued that studies involving hysterectomy should have 
been excluded from this meta-analysis due to the added element of damage to utero-ovarian 
vessels.  However, we included these studies in order to address a well-recognised concern 
over the possible adverse effect of opportunistic salpingectomy during hysterectomy on ovarian 
reserve. We believe this is a clinically important issue that will be of interest to gynecological 
surgeons. Had we found an effect on AMH in the hysterectomy group we would have 
performed a sub-analysis to exclude studies involving hysterectomy.   
Possible explanation for our unexpected results is that the postulated post-salpingectomy 
decline of ovarian reserve may be a chronic process that could take a long time to occur. In 
other words, the possible post-salpingectomy impairment of blood supply may lead to chronic 
ovarian ischemia that could take a relatively long time to cause reduction in the number of the 
small antral follicles with subsequent fall in circulating AMH, which is exclusively secreted 
from these follicles. This hypothesis, however, requires validation through further long-term 
follow up studies on the changes of circulating AMH after salpingectomy. One recent long-
term study revealed no change in circulating AMH up to five years after salpingectomy (28).  
However, these data are inconclusive due to the relatively old age of all participants (mean age, 
44) with very low AMH values at baseline.  
As far as other ovarian reserve markers are concerned, group 1 analysis revealed a small but a 
statistically significant increase in circulating FSH (WMD, 1.75 IU/L). However, given the 
well-known high inter- and intra-cycle variability of circulating FSH, this little change is 
unlikely to reflect a real decline in ovarian reserve. Furthermore, serum FSH level is currently 
considered as an ovarian reserve marker of little clinical value in young  women (29). With 
regards to the AFC, it was interesting to see (in group 2 meta-analysis) lower values in women 
undergoing salpingectomy compared to the healthy controls. This is surprising as AFC 
outcome was expected to be in line with AMH as both correlate well with each other.  It is 
worth mentioning the larger of the two studies in this analysis included participants with 
tubal/adnexal pathology which could have already compromised AFC before surgery. This is 
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supported by the lack of any effect of salpingectomy on AFC in group 1 studies, which 
included participants with no tubal pathology. However, this does not explain the discrepancy 
between AFC and AMH outcomes in group 2 meta-analysis. This issue could only be resolved 
with further studies comparing pre- and post-salpingectomy AFC and circulating AMH in 
women with and without tubal pathology.   
Based on our results, there seems to be no evidence of any short-term compromise to ovarian 
reserve following salpingectomy. However, these results should be interpreted with caution, 
given the short duration of follow up in all studies included in this meta-analysis. Furthermore, 
the lack of any short term decline in serum AMH levels after salpingectomy does not 
necessarily mean that the long-term chances of pregnancy are not compromised by this 
procedure. We therefore recommend that until further evidence becomes available from long-
term follow-up studies, salpingectomy should only be performed when necessary and women 
should be counselled with regards to the uncertainty regarding risks to ovarian reserve. 
Alternative conservative approaches may be advisable whenever possible. 
The main limitations of this meta-analysis are the very small number of the studies included 
and the short duration of follow-up, which make it difficult to draw any objective conclusion 
on the long-term preservation of ovarian function after surgery. Another important limitation is 
the variation in the surgical techniques and tubal pathologies in participants of different studies. 
Furthermore, although circulating AMH is considered the most reliable marker of ovarian 
reserve, it does not directly measure the total follicle pool. It should therefore be considered a 
surrogate marker of ovarian reserve and the results should be interpreted with caution.  
With regards to the quality and risk of bias assessment of the included studies, it is worth 
mentioning that all available tests including the Newcastle-Ottawa scale, which is used in this 
study, are of limited ability when the number of included studies is small. 
In conclusion, salpingectomy seems to have no short-term adverse effect on ovarian reserve. 
However, given the possible concomitant damage to ovarian blood supply during 
salpingectomy, long term adverse effect on ovarian reserve remains a concern that requires 
further investigations. 
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Supporting Information legends 
 
Table S1. Studies excluded from the metaanalysis. 
Table S2. Search strategies for ovarian reserve after salpingectomy. 
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Figure & Tables Legends 
 
Table 1. Modified Newcastle Ottawa scale for risk of bias and quality assessment of the included 
studies. 
 
Table 2. Characteristics of the eight studies included in the meta-analysis. 
 
Table 3 Serum anti-Müllerian hormone (AMH) concentrations after salpingectomy in all eight 
studies. 
 
Figure 1. PRISMA Flow Chart of the study selection process. AMH, anti-Müllerian hormone. 
 
Figure 2. Weighted mean difference in serum anti-Müllerian hormone concentrations after 
salpingectomy: pooled results for all six studies in group 1. CI, confidence interval. 
 
Figure 3. Weighted mean difference in serum anti-Müllerian concentrations after 
salpingectomy: pooled results for two studies in group 2. CI, confidence interval. 
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Table 1 Modified Newcastle Ottawa scale for risk of bias and quality assessment of the included studies 
 
Author Year 
Selection  
(***) 
Comparability  
(****) 
Outcome  
(**)  
Overall  
Group 1 studies      
Findley et al. [9] 2013 ** *** ** 7 
Morelli et al. [10] 2013 * ** ** 5 
Rodgers et al. [11] 2015 * *** ** 6 
Venturella et al. [12] 2015 ** * ** 5 
Sahin et al. [14] 2016 * *** ** 6 
Atalay et al. [21] 2016 * ** ** 5 
Group 2 studies      
Ye et al. [13] 2014 * *** - 4 
Sahin Ersoy et al. 
[15] 
2016 * *** ** 6 
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Table 2 Characteristics of the eight studies included in the meta-analysis 
Authors Year Country Design n 
Age 
mean±SD 
Laterality Pathology 
Follow up 
Months 
AMH 
Kit 
Secondary 
outcomes 
Group 1 studies           
Findley et al [9] 2013 USA Pilot RCT 15 36.6±4.5 bilateral Normal tubes¶ 3* Ansh lab - 
Morelli et al [10] 2013 Italy 
Retrospective 
cohort 
79 45.8 ± 2.4 bilateral Normal tubes¶ 3 Gen II FSH,  AFC 
Rodgers et al [11] 2015 Australia Prospective cohort 20 33.06±4.9 unilateral 
Ectopic 
pregnancy 
4 Gen II - 
Venturella et al 
[12] 
2015 Italy RCT 186 41.36±5.39 bilateral Normal tubes¶¶ 3 Gen II FSH, AFC 
Sahin et al [14] 2016 Turkey Prospective cohort 61 30.9±4.7 unilateral 
Ectopic 
pregnancy 
3 Gen II - 
Atalay et al [21] 2016 Turkey Prospective cohort 103 
TLH 42 (35–
48) 
TAH 44 (36–48) 
 
bilateral Normal tubes 6 
Cusabio 
Biotech  
FSH, OV, 
E2 
Group 2 studies           
Ye et al [13] 
 
2014 
 
China 
 
Retrospective 
cohort 
 
S=12
4 
C=74 
33.2±4.5 
33.8±4.7 
Uni=83 
Bil=41 
Tubal 
pathology** 
 
NS 
 
Bio-Rad 
 
FSH, AFC 
 
Sahin Ersoy et al 
[15] 
 
2016 
 
Turkey 
 
Cross-sectional 
 
S=45 
C=80 
28.3±3.0 
27.2±3.5 
Unilatera
l 
 
Ectopic 
pregnancy 
 
18 
 
Ansh lab 
 
FSH, AFC 
 
* This study also measured serum AMH level at 4-6 weeks postoperatively 
** Tubal pathology (Tuboovarian abscess, ectopic pregnancy, hydrosalpinx)  
 Data presented as median and range 
¶ Tubes removed during with total laparoscopic hysterectomy  
¶¶ Tubes removed during myomectomy or sterilization 
Abbreviations: RCT, randomized controlled trial; AMH, anti-Müllerian hormone; FSH, follicle stimulating 
hormone; AFC, antral follicle count; OV, ovarian volume; S, salpingectomy group; C, control group; Uni, 
unilateral; Bil, bilateral; NS, Not specified; E2. Estradiol; TLH, total laparoscopic hysterectomy; TAH,  
total abdominal hysterectomy 
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Table 3 Serum AMH concentrations after salpingectomy in all eight studies 
Author 
  Serum AMH (ng/ml) 
mean±SD 
Group 1 studies n laterality Preoperative Postoperative 
Findley et al. 2013 [9] 15 Bilateral 2.26 ± 2.72 1.86 ± 1.99 
Morelli et al. 2013 [10] 79 Bilateral 0.49 ± 0.4 0.42±0.4 
Rodgers et al. 2015 [11] 20 Unilateral 3.52±2.5 3.59±3.15 
Venturella et al.  2015 [12] 
Group A*=91 
Group B**=95 
All =186 
Bilateral 
0.93±1.13 
0.86±1.01 
0.89±1.07 
0.83±1.01 
0.79±0.91 
0.80±0.96 
Sahin et al. 2016 [14] 61 Unilateral 2.10±1.74 2.20±1.52 
Atalay et al. 2016 [21] 103 Bilateral 1.98 ± 1.30 1.67 ± 1.06 
Group 2 studies n Laterality Study group Control group 
Ye et al. 2014 [13] S=124 
C=74 
Uni=83 
Bil=41 
Overall=124 
0.02±0.01 
0.01±0.01 
0.01±0.01 
0.02±0.01 
 
Sahin Ersoy et al. 2016 [15] 
S=45 
C=80 
Unilateral 2.68±0.59 2.96±0.85 
*Group A: bilateral salpingectomy without removal of mesosalpinx. 
**Group B: bilateral salpingectomy with removal of part of mesosalpinx 
Abbreviations: S, salpingectomy group; C, control group; Uni, unilateral; Bil, bilateral 
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